Sign in

Rosanne Sprute

@rosannesprute.bsky.social
361 followers 264 following 2 posts

Fungal infections and immunology | MD | Infectious Diseases, Haematology, Oncology | University of Cologne, Germany | YECMM | DZIF | CECAD | FungiScope

PostsRepliesMedia
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 03/02/2026
New AGIHO guideline update on G-CSF prophylaxis in adult cancer patients! Evidence-based recommendations incl. immunotherapy settings, biosimilars & risk stratification to support clinical decision-making. 🔗 pubmed.ncbi.nlm.nih.gov/41570611/ @rosannesprute.bsky.social #Oncology #Guidelines
pubmed.ncbi.nlm.nih.gov
Evidence-based AGIHO guideline update on prophylaxis of infectious complications with granulocyte-stimulating factors (G-CSF) for the treatment of adult patients with cancer - PubMed
Comprehensive literature search and expert panel consensus confirm most of the key recommendations of 2014. New recommendations on the use of G-CSF in immunotherapy settings provide insight and support for day-by-day clinical decision making in the care of patients with cancer.
033
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 27/11/2025
Proud to share our new CMI editorial with @rosannesprute.bsky.social: we highlight the rising challenges in invasive candidiasis-shifting epidemiology, antifungal resistance, precision therapy, and the global threat of C. auris. www.sciencedirect.com/science/arti... #MedicalMycology #Candida
sciencedirect.com
Optimising the management of invasive candidiasis
064
Reposted by Rosanne Sprute
Neil Gow @neil-gow.bsky.social · 22/11/2025
Get ready for a feast of fungal biology at the GRC CMFB conference in Holderness, NH next year. @mrccmm.bsky.social @youngecmm.bsky.social @ishamycology.bsky.social @youngisham.bsky.social @britmycolsoc.org.uk @elainebignell.bsky.social
094
Reposted by Rosanne Sprute
Julio C. Zuniga-Moya @julioczuniga1.bsky.social · 15/11/2025
www.clinicalmicrobiologyandinfection.org/article/S119...
clinicalmicrobiologyandinfection.org
Gender differences in audience participation at infectious disease and microbiology conferences: a prospective observational study
In medicine, women constitute a large proportion of the workforce but remain underrepresented in senior positions. Scientific conferences, critical for career advancement, reflect these inequities, wi...
032
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 10/10/2025
🎧 Infektiopod #99: Candidiasis Gemeinsam mit @rosannesprute.bsky.social spreche ich über die neue globale Leitlinie zur Diagnose und zum Management von Candidiasis – von der Entstehung der Guideline bis zu Diagnostik und Therapie. Jetzt reinhören: infektiopod.de/infektiopod-99-candidiasis/
infektiopod.de
Infektiopod #99: Candidiasis – Infektiopod
042
Reposted by Rosanne Sprute
Seána Duggan @seanaduggan.bsky.social · 09/10/2025
It was a privilege to give a talk yesterday in the polymicrobial interactions & pathogenesis session about my work on the role of copper in Candida - bacterial interactions #Candida2025 @mrccmm.bsky.social @microbiologysociety.org thanks to the wonderful @rosannesprute.bsky.social for the picture
072
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 08/10/2025
Proud to see key antifungal advances featured in The Lancet Infectious Diseases highlights of #ESCMIDGlobal2025. @rosannesprute.bsky.social presented global candidiasis guidelines; I shared FURI study results on ibrexafungerp efficacy. 👉 The Lancet article: www.thelancet.com/journals/lan...
thelancet.com
Highlights of ESCMID Global 2025
The 35th Congress of the European Society of Clinical Microbiology and Infectious Diseases was held in Vienna, Austria, from April 11 to 15, 2025. Syeda Saleha Hassan reports.
074
Reposted by Rosanne Sprute
Sarah Dellière @sarah-delliere.bsky.social · 04/09/2025
✨📄 What about the untapped therapeutic potential of the immune response in invasive aspergillosis ? Here’s some rational, pre-clinical and clinical evidence. Huge thanks to our amazing 🌍 team! 🔗 bit.ly/46kajHr @simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social
0159
Reposted by Rosanne Sprute
Max Planck Institute of Colloids & Interfaces (MPICI) @mpici.bsky.social · 26/09/2025
Replicas of fungal #sugars decode the immune system’s 1st response to dangerous #Candida bloodstream infections. This enables a non-invasive #test that delivers reliable results in minutes—a breakthrough vs. rising health threat. Press release: tinyurl.com/3aychk8u Paper: tinyurl.com/26pkne4u
tinyurl.com
Sugar Fingerprints to Fight Fungal Infections
092
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 26/09/2025
Collaborative research uses glycan microarrays to decode Candida antibody responses in humans & mice. Results guide biomarker discovery and vaccine design—innovating fungal infection care. 🔗 www.pnas.org/doi/10.1073/... #Innovation #FungalInfections #Vaccines #TeamScience
pnas.org
Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development | PNAS
Invasive, high-mortality yeast infections caused by pathogenic Candida species are the most common fungal nosocomial bloodstream infections. The Wo...
021
Reposted by Rosanne Sprute
A Pradhan @apradhan77.bsky.social · 26/09/2025
Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development | PNAS www.pnas.org/doi/10.1073/...
pnas.org
Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development | PNAS
Invasive, high-mortality yeast infections caused by pathogenic Candida species are the most common fungal nosocomial bloodstream infections. The Wo...
021
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 19/09/2025
🌍 TIMM 2025: Join the One Health Lunch Meeting on Sept 21, 2025 (12:30–2:00 PM, Room 3A)! Topic: AMR – Fungal One Health Coalition for global strategies to combat AntiMycotic Resistance. Hosts: Michaela Lackner & Paul Verweij. 🍴 Everyone welcome—bring your colleagues!
024
Reposted by Rosanne Sprute
Neil Gow @neil-gow.bsky.social · 19/09/2025
Great to be up and running at TIMM12 in Bilbao. @youngecmm.bsky.social @ecmmcandidaiv.bsky.social - a feast of medical mycology being basic and clinical mycology. @mrccmm.bsky.social @ishamycology.bsky.social @youngisham.bsky.social
183
Reposted by Rosanne Sprute
Y-ECMM @youngecmm.bsky.social · 14/09/2025
Looking forward to our YECMM Dinner at @TiMM25 ☺️ 📝Registration is still possible: congresscare.eventsair.com/12th-trends-...
042
Reposted by Rosanne Sprute
Iliev Lab @ilievlab.bsky.social · 12/09/2025
Just a few days left for scholarship and short talk submissions! Science, snow, and exciting advances in fungal and immunology research🔬 🍄❄️Claim your spot! #KSFUNGALPATH26 www.keystonesymposia.org/conferences/...
keystonesymposia.org
Fungal Pathogens: Emerging Threats and Future Challenges | Keystone Symposia
Join us at the Keystone Symposia on Fungal Pathogens: Emerging Threats and Future Challenges, January 2026, in Breckenridge, with field leaders!
023
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 07/09/2025
Herzlichen Dank an #DanilaSeidel & @rosannesprute.bsky.social für die großartige Organisation der #MYK 2025! Mit Engagement, Überblick & Herz habt ihr Programm, Location & Gesellschaftsrahmen perfekt gestaltet – viele Details, große Entscheidungen, voller Erfolg! Image © MedizinFotoKöln D. Hensen
273
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 04/09/2025
📅 Thursday at MYK 2025 – Kick off with the Opening Ceremony & Keynote on global fungal strategies. Sessions on host-pathogen interaction, innovative therapies & pediatric infections. Explore posters, industry exhibits & join the welcome reception!
173
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 04/09/2025
What a great start to #MYK2025! Inspiring keynotes, exciting talks & posters, and amazing networking at tonight’s gathering. Wonderful to reconnect with colleagues in mycology - looking forward to the next two days! 🌍🍄✨ Pictures: Dorothea Hensen/MFK
183
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 05/09/2025
📅 Friday at MYK 2025 – Start with the Keynote on global fungal strategies. Sessions on diagnostics, Candida auris, host-pathogen interaction & dermatophytes. Don’t miss Myco-Mania quiz, posters, industry exhibits & the social evening! 👉 dmykg-kongress.de
033
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 03/09/2025
🚨 The ECMM Candida IV Study is enrolling! Retrospective, multicentre, global study on non-albicans candidemia, antifungal resistance & outcomes. 🗓️ Retrospective enrolment: Apr 2024 – Sept 2025 | Data entry open until Mar 2026 🔗 Register your site now: app.carelane.io/1a85ade7-31c... | PIN: 8539
044
Reposted by Rosanne Sprute
CMI Communications @cmicomms.bsky.social · 24/08/2025
🎙️ Just published a new #Communicable episode: Communi... Hosted by Angela Huttner @angelahuttner.bsky.social Josh Nosanchuk @josh-nosanchuk.bsky.social with invited guests: Hatim Sati (@who.int) Dimitrios Kontoyiannis (@mdanderson.bsky.social) Listen here: #IDSky #Clinmicro #MedSky
share.transistor.fm
Communicable E34: WHO's Fungal Priority Pathogens List
Fungal infections and disease have long been overlooked in terms of...
0105
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 25/08/2025
🌍 Save the Date: DZIF/PEG Joint Meeting 2026 – Bridging Disciplines in Infectious Diseases in the Era of Gender & Precision Medicine. Austausch, Innovation & Kollaboration von Bench to Bedside. Mehr Infos 👉 dzif-peg-annual-meeting.de @dzif.bsky.social
054
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 15/07/2025
Die #MYK2025 – 59. Jahrestagung der Deutschsprachigen Mykologischen Gesellschaft – findet vom 4.-6. September in Köln statt. Top-Expert:innen, neueste Forschung & spannende Themen rund um medizinische Mykologie! Mehr Infos & Anmeldung: dmykg-kongress.de #Mykologie
dmykg-kongress.de
59. Wissenschaftliche Tagung der Deutschsprachigen Mykologischen Gesellschaft e. V.
042
Reposted by Rosanne Sprute
Microbiology Society @microbiologysociety.org · 18/06/2025
Society Event Grant – applications for funding to attend Candida and Candidiasis 2025 are now open. Check your eligibility and apply before the deadline 23 June 2025 at 23:59 BST - microb.io/CandidaCandi...
microb.io
Candida and Candidiasis 2025
06 - 09 October 2025
052
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 18/06/2025
New hope for hard-to-treat fungal infections: Phase 2b results show #Olorofim is effective and well-tolerated in patients with few or no treatment options. Read in The Lancet Infectious Diseases 👉 www.sciencedirect.com/science/arti... #IFD #Antifungals #ClinicalTrials
sciencedirect.com
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study
Only a small number of antifungal therapies for invasive fungal disease (IFD) are currently available, and many pathogens are resistant to one or more…
02112
Reposted by Rosanne Sprute
Ursula Hofer @hoferu.bsky.social · 18/06/2025
I'm very excited about this one, novel antifungal!
0155
Reposted by Rosanne Sprute
Ted Pavlic (he/him/his) @tedpavlic.bsky.social · 08/06/2025
Reminder: Nobel-prize winning PCR (1983), used in basically all genetic tech today, was only possible because of extremophile bacterium discovered in 1964 in Yellowstone funded by a small ~$80k NSF grant with no obvious application at the time. #science 🧪 www.richmondscientific.com/how-a-discov...
richmondscientific.com
How a discovery in Yellowstone National Park led to the development of PCR - Richmond Scientific
A discovery in Yellowstone National Park led to the development of PCR, the gold-standard COVID-19 tests used to fight the global pandemic.
221230516
Reposted by Rosanne Sprute
Neil Gow @neil-gow.bsky.social · 03/06/2025
Please repost: We have a postdoc position in Antifungal Immunity Research available to study T cell responses and fungal sensitization in atopic dermatitis. @lableibundgut.bsky.social @neil-gow.bsky.social @mrccmm.bsky.social For more details, visit: jobs.exeter.ac.uk/hrpr_webrecr...
01714
Reposted by Rosanne Sprute
The LeibundGut-lab @lableibundgut.bsky.social · 03/06/2025
Please repost: We are looking for a postdoc interested in Fungal Cell Wall Research to study the Malassezia-host interaction interface in the context of atopic dermatitis. @lableibundgut.bsky.social @neil-gow.bsky.social @mrccmm.bsky.social For more details, visit: jobs.exeter.ac.uk/hrpr_webrecr...
033
Reposted by Rosanne Sprute
ecmmcandidaiv.bsky.social @ecmmcandidaiv.bsky.social · 23/05/2025
Proud to present the progress of ECMM Candida IV study at #ISHAM2025 Still open for participation! @martinhoenigl.bsky.social
042
Reposted by Rosanne Sprute
Universität zu Köln @unicologne.bsky.social · 22/05/2025
🎉Wir freuen uns, fünf Exzellenzcluster! Herzlichen Glückwunsch an @cecad.bsky.social aus der Alternsforschung, @ceplas.bsky.social aus der Pflanzenwissenschaft,@econtribute.bsky.social aus den Wirtschaftswissenschaften, ML4Q aus der Quantenforschung und DYNAVERSE aus der Astrophysik. uni.koeln/XPDTR
2152
Reposted by Rosanne Sprute
Anna Apostolopoulou @annaapostolopoulou.bsky.social · 21/05/2025
⭐Early Career Mycology aficionados⭐: Join us tomorrow for the MSGERC @msgerc.bsky.social Early Career Kickoff Call at 1pm EST! us02web.zoom.us/j/8620666210... Meeting ID: 862 0666 2105 Passcode: 083030 Not an MSGERC member but interested in joining? Check out msgerc.org/membership-a...
254
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 21/05/2025
🚨 Ihre Erfahrung zählt! Unterstützen Sie unsere CAMEO-Umfrage und helfen Sie, die Versorgung bei #Candida #Pilzinfektionen zu verbessern: 👉 www.clinicalsurveys.net/uc/CAMEO/ Jetzt teilnehmen und Forschung mitgestalten! 🧬 #CAMEOStudie #Infektiologie #MedizinischeForschung #IhreErfahrungZählt
033
Rosanne Sprute @rosannesprute.bsky.social · 19/05/2025
And @sarah-delliere.bsky.social reporting on current projects and aims of the YECMM @youngecmm.bsky.social! Have a great session!
040
Reposted by Rosanne Sprute
Microbial Pathogenicity Mechanisms @mpm-hki.bsky.social · 10/05/2025
Congratulations Hans!! 🥳 He received the @dynamic42.bsky.social presentation prize at the #DGHM #EukaryoticPathogens meeting! Hans presented his Master's thesis project about the role of #ECE1 in non-albicans #Candida species. Very well deserved, Hans! 😊❣️🍄 @leibniz-hki.de @uni-jena.de
152
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 16/04/2025
📢 Big news! The Candida Global Guideline will appear in the print edition of The Lancet on April 23rd! Already available online: www.thelancet.com/journals/lan.... A milestone for global fungal care! 🌍🦠 A big thank you to everyone involved in this important work! 🙏 #TheLancet #Candida
thelancet.com
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidias...
064
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 14/04/2025
At ESCMID Global 2025 – learning, growing, and connecting! 🌍📚 Inspiring sessions, new ideas, and the best part: sharing it all with amazing colleagues and meeting great people. Science, progress & fun – what a combo! 🙌 #ESCMID2025 #InfectionExperts #GlobalScience
062
Reposted by Rosanne Sprute
Y-ECMM @youngecmm.bsky.social · 14/04/2025
Great #YECMM networking event ! Thanks to all YECMM members who joined. To be renewed at #ESCMIDGlobal next year ! @rosannesprute.bsky.social @sarah-delliere.bsky.social @neil-gow.bsky.social
0136
Reposted by Rosanne Sprute
Josh Nosanchuk @josh-nosanchuk.bsky.social · 14/04/2025
@acasadevall1.bsky.social Arturo Casadevall dropping wisdom about how climate impacts the potential for #infectious diseases @escmid.bsky.social #ESCMIDGLOBAL2025
1235
Reposted by Rosanne Sprute
ecmmcandidaiv.bsky.social @ecmmcandidaiv.bsky.social · 08/04/2025
ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @martinhoenigl.bsky.social
076
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 13/04/2025
Incredible days at the ESCMID Global 2025! 🌍 Inspiring talks, exciting science, and great conversations with colleagues from around the world. Grateful for the exchange, insights, and energy — science at its best! #ESCMID2025 #InfectiousDiseases #Networking #GlobalHealth
062
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 13/04/2025
Honored to present today at ESCMID Global in Vienna: Ibrexafungerp salvage results from 233 patients in the FURI study — showing high success rates! 🔬💪 A promising new tool in the antifungal pipeline. #ESCMID2025 #FURIstudy #Ibrexafungerp #Antifungals #InfectiousDiseases
0245
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 13/04/2025
Great talk by Rosanne Sprute at ESCMID Global 2025 presenting the new Global Guideline on Candida Diseases! 🦠 A key step for unified care worldwide. Check out the publication here: www.thelancet.com/journals/lan... #ESCMID2025 #Candida #GlobalGuideline
073
Reposted by Rosanne Sprute
Carolina Melchior do Prado @dopradocarol.bsky.social · 05/02/2025
It is with great pleasure that I share our new manuscript! 🔬 A collaborative study between Brazilian, Paraguayan and Dutch researchers sheds light on this emerging fungal infection in Paraguay. 📖 Read here: doi.org/10.1016/j.my... @bramspr.bsky.social
063
Reposted by Rosanne Sprute
Jo Rhodes @drjorhodes.com · 04/04/2025
Abstract submission for the Candida and Candidiasis conference, held in Berlin 6th-9th October 2025, is open until 15th May: microbiologysociety.org/event/societ...
microbiologysociety.org
Candida and Candidiasis 2025
059
Reposted by Rosanne Sprute
Oliver Cornely @olivercornely.bsky.social · 18/03/2025
🔬 New research highlights a potential game-changer in treating invasive mould infections! 🦠 Patients show increased PD-1 expression, suggesting immune checkpoint inhibitors could help fight these deadly infections. More studies needed! 💡 onlinelibrary.wiley.com/doi/10.1111/... #Immunotherapy
onlinelibrary.wiley.com
Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of PD‐1 Inhibition as Potential Treatment Option
Background Invasive mould infections (IMI) cause substantial morbidity and mortality in populations at risk. Novel treatment approaches are urgently needed. Targeting immune checkpoints may reverse ...
074
Reposted by Rosanne Sprute
Martin Hoenigl @martinhoenigl.bsky.social · 02/04/2025
👉Participate in the ECMM Candida IV Study 🌍wide study on candidemia caused by non-albicans Candida Requirement: clinical data & isolate (not req for C.auris) Observation period: 04/2024 - 09/2025 Interested? Email stella.wolfgruber@medunigraz.at
033
Reposted by Rosanne Sprute
Darcy Wooten (she/her) @darcy-id-doc.bsky.social · 02/03/2025
Fantastic tables to help guide management in Candidiasis www.thelancet.com/journals/lan...
thelancet.com
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidias...
041
Reposted by Rosanne Sprute
Judith Berman @judithberman11.bsky.social · 01/03/2025
Nice perspective in Science of work that my great collaborator and TAU colleague, Prof. Micha Fridman, an amazing medicinal chemist, who makes it possible to visualize and think more deeply about antifungal drug interactions with their fungal targets. www.science.org/content/blog...
science.org
What the Antifungals Are Really Doing
052